 activ clarithromycin mycobacterium avium infect patient immun defici syndrom control clinic trial dissemin mycobacterium avium infect common patient immun defici syndrom aid drug studi antimicrobi activ organ trial clarithromycin new macrolid activ avium vitro anim human random double-blind placebo-control trial abil clarithromycin avium bacteremia patient aid infect patient men late-stag aid studi group clarithromycin wk rifampin isoniazid ethambutol clofazimin wk group drug unit cfu avium millilit blood quantit cultur baselin wk minimum inhibitori concentr clarithromycin strain patient baselin agar pH micrograms/ml eight elig patient initi posit cultur declin blood avium cfu case cfu zero patient drug cfu patient undetect elig patient placebo progress cfu increas drug cfu